BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24983928)

  • 1. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
    Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
    Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.
    Mei L; Zhang Q; Yang Y; He Q; Gao H
    Int J Pharm; 2014 Oct; 474(1-2):95-102. PubMed ID: 25138251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
    Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
    J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
    Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
    Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
    Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
    J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
    Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
    Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma.
    Zhang B; Zhang Y; Liao Z; Jiang T; Zhao J; Tuo Y; She X; Shen S; Chen J; Zhang Q; Jiang X; Hu Y; Pang Z
    Biomaterials; 2015 Jan; 36():98-109. PubMed ID: 25443789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
    Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
    Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
    Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
    Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma targeting peptide modified apoferritin nanocage.
    Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
    Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
    Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
    Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
    Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q
    Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.
    Gao H; Qian J; Cao S; Yang Z; Pang Z; Pan S; Fan L; Xi Z; Jiang X; Zhang Q
    Biomaterials; 2012 Jul; 33(20):5115-23. PubMed ID: 22484043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
    Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
    Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
    Gao H; Zhang Q; Yang Y; Jiang X; He Q
    Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
    Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
    Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
    Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
    Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.